西南国防医药2017，Vol.27Issue(8)：824-827,4.DOI:10.3969/j.issn.1004-0188.2017.08.016
钬激光剜除术治疗复发或残留前列腺增生的可行性分析
Feasibility of HoLEP in treatment of recurrent or residual BPH
向宸辉 1王鹏桥 1陈胜龙1
作者信息
- 1. 610500成都,成都医学院第一附属医院泌尿外科
- 折叠
摘要
Abstract
Objective To explore the effects and safety of holmium laser enucleation of prostate (HoLEP) in the treatment of recurrent or residual benign prostatic hyperplasia (BPH) complicated with difficult defecation.Methods A total of 284 patients who had been suffering from BPH and had received HoLEP in our hospital as well as had follow-up data were analyzed retrospectively and divided into two groups according to the medical history:group A (n=75) had BPH operation history before HoLEP,among which 64 ones had recurrent BPH and 11 ones had residual BPH;group B (n =209) had no BPH operation history before HoLEP.The perioperative indexes,operative complications and effects between the two groups were compared.Resuls The two groups successfully received HoLEP and reexamination six months after operation.There was no significant difference in the duration of operation,intraoperative blood loss,bladder irrigation time,urinary catheter indwelling time and length of stay (LOS) between the two groups (P ＞ 0.05).The incidence of post-operative short-term complications between the two groups also showed no significant difference (group A 14.6％ vs group B 11.0％,P ＞ 0.05).The incidence of dysuria was the highest among the post-operative complications (group A 5.3％ vs group B 3.3％),and the second highest one was urethral injury (group A 4.0％ vs group B 2.9％).Corresponding measures were taken and all complications disappeared or were improved.During the six-month follow-up visit after the operation,the two groups had good effects.The international prostate symptom scores (IPSS),quality of life (QOL) scores,post-void residual volume (PVR) and maximum flow rate (Qmax) were greatly improved and showed no significant difference between the two groups (P ＞ 0.05).Conclusion HoLEP is a safe,feasible and effective therapy for the treatment of recurrent or residual BPH.The history of transurethral resection of the prostate (TURP) is not a contraindication of HoLEP.关键词
钬激光/剜除术/前列腺增生/复发/残留/疗效Key words
HoLEP/recurrent or residual BPH/effect分类
医药卫生引用本文复制引用
向宸辉,王鹏桥,陈胜龙..钬激光剜除术治疗复发或残留前列腺增生的可行性分析[J].西南国防医药,2017,27(8):824-827,4.
